FRESENIUS KABI USA FDA Approval ANDA 208231

ANDA 208231

FRESENIUS KABI USA

FDA Drug Application

Application #208231

Documents

Letter2018-09-07

Application Sponsors

ANDA 208231FRESENIUS KABI USA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION1MG/ML0ARSENIC TRIOXIDEARSENIC TRIOXIDE

FDA Submissions

UNKNOWN; ORIG1AP2018-08-31STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

FRESENIUS KABI USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208231
            [companyName] => FRESENIUS KABI USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ARSENIC TRIOXIDE","activeIngredients":"ARSENIC TRIOXIDE","strength":"1MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/31\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/208231Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-08-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.